Cardiovascular benefits of omega-3 polyunsaturated fatty acids /

Mostrar otras versiones (1)

Solvay Pharmaceuticals Conferences.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Maisch, Bernhard, Oelze, R.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam ; Washington, DC : IOS Press, ©2006.
Colección:Solvay Pharmaceuticals Conferences ; v. 7.
Temas:
Heart > Diseases > Congresses.
Omega-3 fatty acids > Therapeutic use > Congresses.
Fatty Acids, Omega-3 > therapeutic use
Heart Diseases > prevention & control
Cœur > Maladies > Congrès.
Acides gras oméga 3 > Emploi en thérapeutique > Congrès.
HEALTH & FITNESS > Nutrition.
HEALTH & FITNESS > Diets.
MEDICAL > Nutrition.
MEDICAL > Nursing > Nutrition.
HEALTH & FITNESS > Food Content Guides.
Heart > Diseases.
Omega-3 fatty acids > Therapeutic use.
Congress
Conference papers and proceedings.
Actes de congrès.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Title page; Preface; List of Contributors; Contents; Conference Preface; Keynote Lecture
  • Risk Factors for Atherosclerotic Disease: Present and Future; Microdetermination of Fatty Acids by Gas Chromatography and Cardiovascular Risk Stratification by the "EPA+DHA Level"; Highly Purified Omega-3 Polyunsaturated Fatty Acids Are Effective as Adjunct Therapy for Secondary Prevention of Myocardial Infarction: Critical Analysis of GISSI-Prevenzione Trial; Prevention of Cardiovascular Diseases and Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs).
  • Omega-3 Fatty Acids and Sudden Arrhythmic DeathDepression and Coronary Artery Disease: Epidemiology and Potential Mechanisms; Effects of Omega-3 Polyunsaturated Fatty Acids on Depression; A Multi-Country Health-Economic Evaluation of Highly Concentrated n-3 Polyunsaturated Fatty Acids (PUFAs) in the Secondary Prevention After Myocardial Infarction (MI); OMACOR® in Clinical Development: A Survey of Current Trials; Author Index.

Ejemplares similares